Repatha, a new drug from Amgen, prevents heart attacks and strokes better than any medicine since the cholesterol-lowering statin drugs that are a daily preventative for millions of middle-aged people ...

The market's reaction to Amgen (AMGN +0.11%) and Sanofi/ Regeneron's PCSK9 drugs (Repatha and Praluent, respectively) has been tepid at best. These drugs, earlier lauded as "blockbusters in waiting," ...

Most Medicare Part D plans include coverage for Repatha, though specific coverage details can vary among plans. Out-of-pocket costs for Repatha under Medicare Part D typically average around $49 per ...